Clinical Trial Update: The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section [Phase 2, Phase 3]

View source ↗

Summary

The STOP CLOT Pilot Study evaluated low molecular weight heparin for preventing venous thromboembolism in high-risk cesarean section patients; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Deep Vein Thrombosis | Phase 2, Phase 3 | Status: COMPLETED